Immunotherapy and biomarkers: Developments in Combination Therapy for Cancer
Over the past few years, increasing evidence has supported the role of biomarkers in immunotherapy. Combination therapy - the use of a combination of products or modalities to treat cancer - is one way to use biomarkers to reveal the...
4 years agoImmunotherapy and biomarkers: Developments in Combination Therapy for Cancer
Over the past few years, increasing evidence has supported the role of biomarkers in immunotherapy. Combination therapy - the use of a combination of products or modalities to treat cancer - is one way to use biomarkers to reveal the...
4 years ago
Weekly News Round-up – 1/4/21
In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech...
4 years agoWeekly News Round-up – 1/4/21
In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech...
4 years ago
The Challenges of Drug Delivery: An Interview With Prof. Afzal R Mohammed
Conventional drug delivery methods, such as oral and systemic administration, face issues of optimisation, and present certain challenges for physicians. Proventa spoke to Professor Afzal Ur-Rahman Mohammed, Head of Pharmaceutical Sciences at Aston University Pharmacy School, about these challenges, and...
4 years agoThe Challenges of Drug Delivery: An Interview With Prof. Afzal R Mohammed
Conventional drug delivery methods, such as oral and systemic administration, face issues of optimisation, and present certain challenges for physicians. Proventa spoke to Professor Afzal Ur-Rahman Mohammed, Head of Pharmaceutical Sciences at Aston University Pharmacy School, about these challenges, and...
4 years ago
Evaluating methods targeting Protein-Protein Interactions: A Clinical Demand
Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer. The issue, however, is developing an effective way of targeting them. The latest advancements in methods targeting PPIs are designed to overcome the challenges limiting...
4 years agoEvaluating methods targeting Protein-Protein Interactions: A Clinical Demand
Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer. The issue, however, is developing an effective way of targeting them. The latest advancements in methods targeting PPIs are designed to overcome the challenges limiting...
4 years ago
Weekly News Round-Up – 26/3/21
In the news this week, reports urge pharmaceutical companies to exploit the benefits of synthetic data in clinical trials. In other news, FDA fears over the safety of tanezumab compromises approval for the Pfizer/Lilly pain drug, and the COSMIC database...
4 years agoWeekly News Round-Up – 26/3/21
In the news this week, reports urge pharmaceutical companies to exploit the benefits of synthetic data in clinical trials. In other news, FDA fears over the safety of tanezumab compromises approval for the Pfizer/Lilly pain drug, and the COSMIC database...
4 years ago
Plant-Derived Vaccines Versus COVID-19
Despite success with the COVID-19 vaccine roll-out, ever-increasing demand across the world continues to put pressure on vaccine manufacturing and supply chains. Recent developments in plant-derived vaccines, however, offer a potential solution. GSK is one company currently implementing phase III...
4 years agoPlant-Derived Vaccines Versus COVID-19
Despite success with the COVID-19 vaccine roll-out, ever-increasing demand across the world continues to put pressure on vaccine manufacturing and supply chains. Recent developments in plant-derived vaccines, however, offer a potential solution. GSK is one company currently implementing phase III...
4 years ago
Innovations in Oncology: An Interview with Raluca Budiu-Predoiu
“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...
4 years agoInnovations in Oncology: An Interview with Raluca Budiu-Predoiu
“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...
4 years ago
Weekly News Round-up – 12/3/21
In the news this week,real-world data has found the Pfizer vaccine to have high effectiveness against asymptomatic COVID-19. In other news, the EMA has advised continued use of AstraZeneca’s vaccine despite blood clot scares, and Zolgensma is set to be...
4 years agoWeekly News Round-up – 12/3/21
In the news this week,real-world data has found the Pfizer vaccine to have high effectiveness against asymptomatic COVID-19. In other news, the EMA has advised continued use of AstraZeneca’s vaccine despite blood clot scares, and Zolgensma is set to be...
4 years ago
Weekly News Round-up – 5/3/21
In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...
4 years agoWeekly News Round-up – 5/3/21
In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...
4 years ago
Data Capture, Integration and Storage in Decentralised Trials
Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...
4 years agoData Capture, Integration and Storage in Decentralised Trials
Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...
4 years ago